This work is licensed under a Creative Commons Attribution 4.0 International License.
[C2A, C9A, C20S, C27S]GeXIVA
General Information
DCTPep ID DCTPep06253
Peptide Name [C2A, C9A, C20S, C27S]GeXIVA
Sequence TARSSGRYARSPYDRRRRYSRRITDASV
Sequence Length 28
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
ACP Cancer targeted peptides α9α10nAChR inhibitor
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target α9α10nAChR
Affinity IC50=6.1 nM (Blocking α9α10nAChR)
Mechanism Specifically block the α9α10nAChR
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C139H231N55O43
Absent amino acids CEFHKLMNQW
Theoretical pI 11.71
Acidic residues 2
Basic residues 9
Polar residues 11
Molecular weight (Average) 3360.71
Molecular weight (Monoisotopic) 3358.76
Common amino acids R
Net charge 7
Instability index (II) 161.14
Aliphatic index 35.00
Grand average of hydropathicity (GRAVY) -1.596
Half Life
7.2 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 4470
Abs 0.1% (=1 g/l) 1.330
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID CN112010972A
Patent Title Novel alpha O-conotoxin peptide GeXIVA new mutant as well as pharmaceutical composition and application thereof
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.